1 Market Overview

1.1 Product Overview and Scope of Bi-Specific MAbS

1.2 Classification of Bi-Specific MAbS by Type

1.2.1 Overview: Global Bi-Specific MAbS Market Size by Type: 2020 Versus 2021 Versus 2026

1.2.2 Global Bi-Specific MAbS Revenue Market Share by Type in 2020

1.2.3 Catumaxomab

1.2.4 Blinatumomab

1.2.5 Duligotumab

1.2.6 SAR 156597

1.3 Global Bi-Specific MAbS Market by Application

1.3.1 Overview: Global Bi-Specific MAbS Market Size by Application: 2020 Versus 2021 Versus 2026

1.3.2 Cancer

1.3.3 Autoimmune Diseases

1.3.4 Inflammatory Diseases

1.3.5 Infectious Diseases

1.3.6 Microbial Diseases

1.3.7 Others

1.4 Global Bi-Specific MAbS Market Size & Forecast

1.5 Global Bi-Specific MAbS Market Size and Forecast by Region

1.5.1 Global Bi-Specific MAbS Market Size by Region: 2016 VS 2021 VS 2026

1.5.2 Global Bi-Specific MAbS Market Size by Region, (2016-2021)

1.5.3 North America Bi-Specific MAbS Market Size and Prospect (2016-2026)

1.5.4 Europe Bi-Specific MAbS Market Size and Prospect (2016-2026)

1.5.5 Asia-Pacific Bi-Specific MAbS Market Size and Prospect (2016-2026)

1.5.6 South America Bi-Specific MAbS Market Size and Prospect (2016-2026)

1.5.7 Middle East and Africa Bi-Specific MAbS Market Size and Prospect (2016-2026)

1.6 Market Drivers, Restraints and Trends

1.6.1 Bi-Specific MAbS Market Drivers

1.6.2 Bi-Specific MAbS Market Restraints

1.6.3 Bi-Specific MAbS Trends Analysis

2 Company Profiles

2.1 Johnson and Johnson

2.1.1 Johnson and Johnson Details

2.1.2 Johnson and Johnson Major Business

2.1.3 Johnson and Johnson Bi-Specific MAbS Product and Solutions

2.1.4 Johnson and Johnson Bi-Specific MAbS Revenue, Gross Margin and Market Share (2019-2021)

2.1.5 Johnson and Johnson Recent Developments and Future Plans

2.2 Novartis AG

2.2.1 Novartis AG Details

2.2.2 Novartis AG Major Business

2.2.3 Novartis AG Bi-Specific MAbS Product and Solutions

2.2.4 Novartis AG Bi-Specific MAbS Revenue, Gross Margin and Market Share (2019-2021)

2.2.5 Novartis AG Recent Developments and Future Plans

2.3 Hoffmann-La Roche Ltd.

2.3.1 Hoffmann-La Roche Ltd. Details

2.3.2 Hoffmann-La Roche Ltd. Major Business

2.3.3 Hoffmann-La Roche Ltd. Bi-Specific MAbS Product and Solutions

2.3.4 Hoffmann-La Roche Ltd. Bi-Specific MAbS Revenue, Gross Margin and Market Share (2019-2021)

2.3.5 Hoffmann-La Roche Ltd. Recent Developments and Future Plans

2.4 Chugai Pharmaceutical

2.4.1 Chugai Pharmaceutical Details

2.4.2 Chugai Pharmaceutical Major Business

2.4.3 Chugai Pharmaceutical Bi-Specific MAbS Product and Solutions

2.4.4 Chugai Pharmaceutical Bi-Specific MAbS Revenue, Gross Margin and Market Share (2019-2021)

2.4.5 Chugai Pharmaceutical Recent Developments and Future Plans

2.5 Bayer AG

2.5.1 Bayer AG Details

2.5.2 Bayer AG Major Business

2.5.3 Bayer AG Bi-Specific MAbS Product and Solutions

2.5.4 Bayer AG Bi-Specific MAbS Revenue, Gross Margin and Market Share (2019-2021)

2.5.5 Bayer AG Recent Developments and Future Plans

2.6 Thermo Fisher Scientific

2.6.1 Thermo Fisher Scientific Details

2.6.2 Thermo Fisher Scientific Major Business

2.6.3 Thermo Fisher Scientific Bi-Specific MAbS Product and Solutions

2.6.4 Thermo Fisher Scientific Bi-Specific MAbS Revenue, Gross Margin and Market Share (2019-2021)

2.6.5 Thermo Fisher Scientific Recent Developments and Future Plans

2.7 Bistro-Myers Squibb

2.7.1 Bistro-Myers Squibb Details

2.7.2 Bistro-Myers Squibb Major Business

2.7.3 Bistro-Myers Squibb Bi-Specific MAbS Product and Solutions

2.7.4 Bistro-Myers Squibb Bi-Specific MAbS Revenue, Gross Margin and Market Share (2019-2021)

2.7.5 Bistro-Myers Squibb Recent Developments and Future Plans

2.8 Mylan N.V.

2.8.1 Mylan N.V. Details

2.8.2 Mylan N.V. Major Business

2.8.3 Mylan N.V. Bi-Specific MAbS Product and Solutions

2.8.4 Mylan N.V. Bi-Specific MAbS Revenue, Gross Margin and Market Share (2019-2021)

2.8.5 Mylan N.V. Recent Developments and Future Plans

2.9 Daiichi Sankyo Company

2.9.1 Daiichi Sankyo Company Details

2.9.2 Daiichi Sankyo Company Major Business

2.9.3 Daiichi Sankyo Company Bi-Specific MAbS Product and Solutions

2.9.4 Daiichi Sankyo Company Bi-Specific MAbS Revenue, Gross Margin and Market Share (2019-2021)

2.9.5 Daiichi Sankyo Company Recent Developments and Future Plans

2.10 Abbott

2.10.1 Abbott Details

2.10.2 Abbott Major Business

2.10.3 Abbott Bi-Specific MAbS Product and Solutions

2.10.4 Abbott Bi-Specific MAbS Revenue, Gross Margin and Market Share (2019-2021)

2.10.5 Abbott Recent Developments and Future Plans

2.11 AstraZeneca

2.11.1 AstraZeneca Details

2.11.2 AstraZeneca Major Business

2.11.3 AstraZeneca Bi-Specific MAbS Product and Solutions

2.11.4 AstraZeneca Bi-Specific MAbS Revenue, Gross Margin and Market Share (2019-2021)

2.11.5 AstraZeneca Recent Developments and Future Plans

2.12 Eli Lilly

2.12.1 Eli Lilly Details

2.12.2 Eli Lilly Major Business

2.12.3 Eli Lilly Bi-Specific MAbS Product and Solutions

2.12.4 Eli Lilly Bi-Specific MAbS Revenue, Gross Margin and Market Share (2019-2021)

2.12.5 Eli Lilly Recent Developments and Future Plans

2.13 Merck and Co.

2.13.1 Merck and Co. Details

2.13.2 Merck and Co. Major Business

2.13.3 Merck and Co. Bi-Specific MAbS Product and Solutions

2.13.4 Merck and Co. Bi-Specific MAbS Revenue, Gross Margin and Market Share (2019-2021)

2.13.5 Merck and Co. Recent Developments and Future Plans

2.14 Amgen

2.14.1 Amgen Details

2.14.2 Amgen Major Business

2.14.3 Amgen Bi-Specific MAbS Product and Solutions

2.14.4 Amgen Bi-Specific MAbS Revenue, Gross Margin and Market Share (2019-2021)

2.14.5 Amgen Recent Developments and Future Plans

2.15 Pfizer

2.15.1 Pfizer Details

2.15.2 Pfizer Major Business

2.15.3 Pfizer Bi-Specific MAbS Product and Solutions

2.15.4 Pfizer Bi-Specific MAbS Revenue, Gross Margin and Market Share (2019-2021)

2.15.5 Pfizer Recent Developments and Future Plans

2.16 GlaxoSmithKline plc

2.16.1 GlaxoSmithKline plc Details

2.16.2 GlaxoSmithKline plc Major Business

2.16.3 GlaxoSmithKline plc Bi-Specific MAbS Product and Solutions

2.16.4 GlaxoSmithKline plc Bi-Specific MAbS Revenue, Gross Margin and Market Share (2019-2021)

2.16.5 GlaxoSmithKline plc Recent Developments and Future Plans

2.17 Roche

2.17.1 Roche Details

2.17.2 Roche Major Business

2.17.3 Roche Bi-Specific MAbS Product and Solutions

2.17.4 Roche Bi-Specific MAbS Revenue, Gross Margin and Market Share (2019-2021)

2.17.5 Roche Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Bi-Specific MAbS Revenue and Share by Players (2019-2021)

3.2 Market Concentration Rate

3.2.1 Top 3 Bi-Specific MAbS Players Market Share

3.2.2 Top 10 Bi-Specific MAbS Players Market Share

3.2.3 Market Competition Trend

3.3 Bi-Specific MAbS Players Head Office, Products and Services Provided

3.4 Mergers & Acquisitions

3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Bi-Specific MAbS Revenue and Market Share by Type (2016-2021)

4.2 Global Bi-Specific MAbS Market Forecast by Type (2021-2026)

5 Market Size Segment by Application

5.1 Global Bi-Specific MAbS Revenue Market Share by Application (2016-2021)

5.2 Bi-Specific MAbS Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application

6.1 North America Bi-Specific MAbS Revenue by Type (2016-2026)

6.2 North America Bi-Specific MAbS Revenue by Application (2016-2026)

6.3 North America Bi-Specific MAbS Market Size by Country

6.3.1 North America Bi-Specific MAbS Revenue by Country (2016-2026)

6.3.2 United States Bi-Specific MAbS Market Size and Forecast (2016-2026)

6.3.3 Canada Bi-Specific MAbS Market Size and Forecast (2016-2026)

6.3.4 Mexico Bi-Specific MAbS Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application

7.1 Europe Bi-Specific MAbS Revenue by Type (2016-2026)

7.2 Europe Bi-Specific MAbS Revenue by Application (2016-2026)

7.3 Europe Bi-Specific MAbS Market Size by Country

7.3.1 Europe Bi-Specific MAbS Revenue by Country (2016-2026)

7.3.2 Germany Bi-Specific MAbS Market Size and Forecast (2016-2026)

7.3.3 France Bi-Specific MAbS Market Size and Forecast (2016-2026)

7.3.4 United Kingdom Bi-Specific MAbS Market Size and Forecast (2016-2026)

7.3.5 Russia Bi-Specific MAbS Market Size and Forecast (2016-2026)

7.3.6 Italy Bi-Specific MAbS Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Bi-Specific MAbS Revenue by Type (2016-2026)

8.2 Asia-Pacific Bi-Specific MAbS Revenue by Application (2016-2026)

8.3 Asia-Pacific Bi-Specific MAbS Market Size by Region

8.3.1 Asia-Pacific Bi-Specific MAbS Revenue by Region (2016-2026)

8.3.2 China Bi-Specific MAbS Market Size and Forecast (2016-2026)

8.3.3 Japan Bi-Specific MAbS Market Size and Forecast (2016-2026)

8.3.4 South Korea Bi-Specific MAbS Market Size and Forecast (2016-2026)

8.3.5 India Bi-Specific MAbS Market Size and Forecast (2016-2026)

8.3.6 Southeast Asia Bi-Specific MAbS Market Size and Forecast (2016-2026)

8.3.7 Australia Bi-Specific MAbS Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application

9.1 South America Bi-Specific MAbS Revenue by Type (2016-2026)

9.2 South America Bi-Specific MAbS Revenue by Application (2016-2026)

9.3 South America Bi-Specific MAbS Market Size by Country

9.3.1 South America Bi-Specific MAbS Revenue by Country (2016-2026)

9.3.2 Brazil Bi-Specific MAbS Market Size and Forecast (2016-2026)

9.3.3 Argentina Bi-Specific MAbS Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Bi-Specific MAbS Revenue by Type (2016-2026)

10.2 Middle East & Africa Bi-Specific MAbS Revenue by Application (2016-2026)

10.3 Middle East & Africa Bi-Specific MAbS Market Size by Country

10.3.1 Middle East & Africa Bi-Specific MAbS Revenue by Country (2016-2026)

10.3.2 Turkey Bi-Specific MAbS Market Size and Forecast (2016-2026)

10.3.3 Saudi Arabia Bi-Specific MAbS Market Size and Forecast (2016-2026)

10.3.4 UAE Bi-Specific MAbS Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Bi-Specific MAbS Revenue by Type, (USD Million), 2020 VS 2021 VS 2026

Table 2. Global Bi-Specific MAbS Revenue by Application, (USD Million), 2020 VS 2021 VS 2026

Table 3. Global Market Bi-Specific MAbS Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)

Table 4. Global Bi-Specific MAbS Revenue (USD Million) by Region (2016-2021)

Table 5. Global Bi-Specific MAbS Revenue Market Share by Region (2021-2026)

Table 6. Johnson and Johnson Corporate Information, Head Office, and Major Competitors

Table 7. Johnson and Johnson Major Business

Table 8. Johnson and Johnson Bi-Specific MAbS Product and Solutions

Table 9. Johnson and Johnson Bi-Specific MAbS Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 10. Novartis AG Corporate Information, Head Office, and Major Competitors

Table 11. Novartis AG Major Business

Table 12. Novartis AG Bi-Specific MAbS Product and Solutions

Table 13. Novartis AG Bi-Specific MAbS Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 14. Hoffmann-La Roche Ltd. Corporate Information, Head Office, and Major Competitors

Table 15. Hoffmann-La Roche Ltd. Major Business

Table 16. Hoffmann-La Roche Ltd. Bi-Specific MAbS Product and Solutions

Table 17. Hoffmann-La Roche Ltd. Bi-Specific MAbS Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 18. Chugai Pharmaceutical Corporate Information, Head Office, and Major Competitors

Table 19. Chugai Pharmaceutical Major Business

Table 20. Chugai Pharmaceutical Bi-Specific MAbS Product and Solutions

Table 21. Chugai Pharmaceutical Bi-Specific MAbS Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 22. Bayer AG Corporate Information, Head Office, and Major Competitors

Table 23. Bayer AG Major Business

Table 24. Bayer AG Bi-Specific MAbS Product and Solutions

Table 25. Bayer AG Bi-Specific MAbS Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 26. Thermo Fisher Scientific Corporate Information, Head Office, and Major Competitors

Table 27. Thermo Fisher Scientific Major Business

Table 28. Thermo Fisher Scientific Bi-Specific MAbS Product and Solutions

Table 29. Thermo Fisher Scientific Bi-Specific MAbS Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 30. Bistro-Myers Squibb Corporate Information, Head Office, and Major Competitors

Table 31. Bistro-Myers Squibb Major Business

Table 32. Bistro-Myers Squibb Bi-Specific MAbS Product and Solutions

Table 33. Bistro-Myers Squibb Bi-Specific MAbS Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 34. Mylan N.V. Corporate Information, Head Office, and Major Competitors

Table 35. Mylan N.V. Major Business

Table 36. Mylan N.V. Bi-Specific MAbS Product and Solutions

Table 37. Mylan N.V. Bi-Specific MAbS Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 38. Daiichi Sankyo Company Corporate Information, Head Office, and Major Competitors

Table 39. Daiichi Sankyo Company Major Business

Table 40. Daiichi Sankyo Company Bi-Specific MAbS Product and Solutions

Table 41. Daiichi Sankyo Company Bi-Specific MAbS Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 42. Abbott Corporate Information, Head Office, and Major Competitors

Table 43. Abbott Major Business

Table 44. Abbott Bi-Specific MAbS Product and Solutions

Table 45. Abbott Bi-Specific MAbS Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 46. AstraZeneca Corporate Information, Head Office, and Major Competitors

Table 47. AstraZeneca Major Business

Table 48. AstraZeneca Bi-Specific MAbS Product and Solutions

Table 49. AstraZeneca Bi-Specific MAbS Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 50. Eli Lilly Corporate Information, Head Office, and Major Competitors

Table 51. Eli Lilly Major Business

Table 52. Eli Lilly Bi-Specific MAbS Product and Solutions

Table 53. Eli Lilly Bi-Specific MAbS Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 54. Merck and Co. Corporate Information, Head Office, and Major Competitors

Table 55. Merck and Co. Major Business

Table 56. Merck and Co. Bi-Specific MAbS Product and Solutions

Table 57. Merck and Co. Bi-Specific MAbS Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 58. Amgen Corporate Information, Head Office, and Major Competitors

Table 59. Amgen Major Business

Table 60. Amgen Bi-Specific MAbS Product and Solutions

Table 61. Amgen Bi-Specific MAbS Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 62. Pfizer Corporate Information, Head Office, and Major Competitors

Table 63. Pfizer Major Business

Table 64. Pfizer Bi-Specific MAbS Product and Solutions

Table 65. Pfizer Bi-Specific MAbS Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 66. GlaxoSmithKline plc Corporate Information, Head Office, and Major Competitors

Table 67. GlaxoSmithKline plc Major Business

Table 68. GlaxoSmithKline plc Bi-Specific MAbS Product and Solutions

Table 69. GlaxoSmithKline plc Bi-Specific MAbS Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 70. Roche Corporate Information, Head Office, and Major Competitors

Table 71. Roche Major Business

Table 72. Roche Bi-Specific MAbS Product and Solutions

Table 73. Roche Bi-Specific MAbS Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 74. Global Bi-Specific MAbS Revenue (USD Million) by Players (2019-2021)

Table 75. Global Bi-Specific MAbS Revenue Share by Players (2019-2021)

Table 76. Breakdown of Bi-Specific MAbS by Company Type (Tier 1, Tier 2 and Tier 3)

Table 77. Bi-Specific MAbS Players Head Office, Products and Services Provided

Table 78. Bi-Specific MAbS Mergers & Acquisitions in the Past Five Years

Table 79. Bi-Specific MAbS New Entrants and Expansion Plans

Table 80. Global Bi-Specific MAbS Revenue (USD Million) by Type (2016-2021)

Table 81. Global Bi-Specific MAbS Revenue Share by Type (2016-2021)

Table 82. Global Bi-Specific MAbS Revenue Forecast by Type (2021-2026)

Table 83. Global Bi-Specific MAbS Revenue by Application (2016-2021)

Table 84. Global Bi-Specific MAbS Revenue Forecast by Application (2021-2026)

Table 85. North America Bi-Specific MAbS Revenue by Type (2016-2021) & (USD Million)

Table 86. North America Bi-Specific MAbS Revenue by Type (2021-2026) & (USD Million)

Table 87. North America Bi-Specific MAbS Revenue by Application (2016-2021) & (USD Million)

Table 88. North America Bi-Specific MAbS Revenue by Application (2021-2026) & (USD Million)

Table 89. North America Bi-Specific MAbS Revenue by Country (2016-2021) & (USD Million)

Table 90. North America Bi-Specific MAbS Revenue by Country (2021-2026) & (USD Million)

Table 91. Europe Bi-Specific MAbS Revenue by Type (2016-2021) & (USD Million)

Table 92. Europe Bi-Specific MAbS Revenue by Type (2021-2026) & (USD Million)

Table 93. Europe Bi-Specific MAbS Revenue by Application (2016-2021) & (USD Million)

Table 94. Europe Bi-Specific MAbS Revenue by Application (2021-2026) & (USD Million)

Table 95. Europe Bi-Specific MAbS Revenue by Country (2016-2021) & (USD Million)

Table 96. Europe Bi-Specific MAbS Revenue by Country (2021-2026) & (USD Million)

Table 97. Asia-Pacific Bi-Specific MAbS Revenue by Type (2016-2021) & (USD Million)

Table 98. Asia-Pacific Bi-Specific MAbS Revenue by Type (2021-2026) & (USD Million)

Table 99. Asia-Pacific Bi-Specific MAbS Revenue by Application (2016-2021) & (USD Million)

Table 100. Asia-Pacific Bi-Specific MAbS Revenue by Application (2021-2026) & (USD Million)

Table 101. Asia-Pacific Bi-Specific MAbS Revenue by Region (2016-2021) & (USD Million)

Table 102. Asia-Pacific Bi-Specific MAbS Revenue by Region (2021-2026) & (USD Million)

Table 103. South America Bi-Specific MAbS Revenue by Type (2016-2021) & (USD Million)

Table 104. South America Bi-Specific MAbS Revenue by Type (2021-2026) & (USD Million)

Table 105. South America Bi-Specific MAbS Revenue by Application (2016-2021) & (USD Million)

Table 106. South America Bi-Specific MAbS Revenue by Application (2021-2026) & (USD Million)

Table 107. South America Bi-Specific MAbS Revenue by Country (2016-2021) & (USD Million)

Table 108. South America Bi-Specific MAbS Revenue by Country (2021-2026) & (USD Million)

Table 109. Middle East & Africa Bi-Specific MAbS Revenue by Type (2016-2021) & (USD Million)

Table 110. Middle East & Africa Bi-Specific MAbS Revenue by Type (2021-2026) & (USD Million)

Table 111. Middle East & Africa Bi-Specific MAbS Revenue by Application (2016-2021) & (USD Million)

Table 112. Middle East & Africa Bi-Specific MAbS Revenue by Application (2021-2026) & (USD Million)

Table 113. Middle East & Africa Bi-Specific MAbS Revenue by Country (2016-2021) & (USD Million)

Table 114. Middle East & Africa Bi-Specific MAbS Revenue by Country (2021-2026) & (USD Million)

List of Figures

Figure 1. Bi-Specific MAbS Picture

Figure 2. Global Bi-Specific MAbS Revenue Market Share by Type in 2020

Figure 3. Catumaxomab

Figure 4. Blinatumomab

Figure 5. Duligotumab

Figure 6. SAR 156597

Figure 7. Bi-Specific MAbS Revenue Market Share by Application in 2020

Figure 8. Cancer Picture

Figure 9. Autoimmune Diseases Picture

Figure 10. Inflammatory Diseases Picture

Figure 11. Infectious Diseases Picture

Figure 12. Microbial Diseases Picture

Figure 13. Others Picture

Figure 14. Global Bi-Specific MAbS Revenue, (USD Million): 2020 VS 2021 VS 2026

Figure 15. Global Bi-Specific MAbS Revenue and Forecast (2016-2026) & (USD Million)

Figure 16. Global Bi-Specific MAbS Revenue Market Share by Region (2016-2026)

Figure 17. Global Bi-Specific MAbS Revenue Market Share by Region in 2020

Figure 18. North America Bi-Specific MAbS Revenue (USD Million) and Growth Rate (2016-2026)

Figure 19. Europe Bi-Specific MAbS Revenue (USD Million) and Growth Rate (2016-2026)

Figure 20. Asia-Pacific Bi-Specific MAbS Revenue (USD Million) and Growth Rate (2016-2026)

Figure 21. South America Bi-Specific MAbS Revenue (USD Million) and Growth Rate (2016-2026)

Figure 22. Middle East and Africa Bi-Specific MAbS Revenue (USD Million) and Growth Rate (2016-2026)

Figure 23. Bi-Specific MAbS Market Drivers

Figure 24. Bi-Specific MAbS Market Restraints

Figure 25. Bi-Specific MAbS Market Trends

Figure 26. Johnson and Johnson Recent Developments and Future Plans

Figure 27. Novartis AG Recent Developments and Future Plans

Figure 28. Hoffmann-La Roche Ltd. Recent Developments and Future Plans

Figure 29. Chugai Pharmaceutical Recent Developments and Future Plans

Figure 30. Bayer AG Recent Developments and Future Plans

Figure 31. Thermo Fisher Scientific Recent Developments and Future Plans

Figure 32. Bistro-Myers Squibb Recent Developments and Future Plans

Figure 33. Mylan N.V. Recent Developments and Future Plans

Figure 34. Daiichi Sankyo Company Recent Developments and Future Plans

Figure 35. Abbott Recent Developments and Future Plans

Figure 36. AstraZeneca Recent Developments and Future Plans

Figure 37. Eli Lilly Recent Developments and Future Plans

Figure 38. Merck and Co. Recent Developments and Future Plans

Figure 39. Amgen Recent Developments and Future Plans

Figure 40. Pfizer Recent Developments and Future Plans

Figure 41. GlaxoSmithKline plc Recent Developments and Future Plans

Figure 42. Roche Recent Developments and Future Plans

Figure 43. Global Bi-Specific MAbS Revenue Share by Players in 2020

Figure 44. Bi-Specific MAbS Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

Figure 45. Global Top 3 Players Bi-Specific MAbS Revenue Market Share in 2020

Figure 46. Global Top 10 Players Bi-Specific MAbS Revenue Market Share in 2020

Figure 47. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)

Figure 48. Global Bi-Specific MAbS Revenue Share by Type in 2020

Figure 49. Global Bi-Specific MAbS Market Share Forecast by Type (2021-2026)

Figure 50. Global Bi-Specific MAbS Revenue Share by Application in 2020

Figure 51. Global Bi-Specific MAbS Market Share Forecast by Application (2021-2026)

Figure 52. North America Bi-Specific MAbS Sales Market Share by Type (2016-2026)

Figure 53. North America Bi-Specific MAbS Sales Market Share by Application (2016-2026)

Figure 54. North America Bi-Specific MAbS Revenue Market Share by Country (2016-2026)

Figure 55. United States Bi-Specific MAbS Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 56. Canada Bi-Specific MAbS Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 57. Mexico Bi-Specific MAbS Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 58. Europe Bi-Specific MAbS Sales Market Share by Type (2016-2026)

Figure 59. Europe Bi-Specific MAbS Sales Market Share by Application (2016-2026)

Figure 60. Europe Bi-Specific MAbS Revenue Market Share by Country (2016-2026)

Figure 61. Germany Bi-Specific MAbS Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 62. France Bi-Specific MAbS Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 63. United Kingdom Bi-Specific MAbS Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 64. Russia Bi-Specific MAbS Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 65. Italy Bi-Specific MAbS Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 66. Asia-Pacific Bi-Specific MAbS Sales Market Share by Type (2016-2026)

Figure 67. Asia-Pacific Bi-Specific MAbS Sales Market Share by Application (2016-2026)

Figure 68. Asia-Pacific Bi-Specific MAbS Revenue Market Share by Region (2016-2026)

Figure 69. China Bi-Specific MAbS Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 70. Japan Bi-Specific MAbS Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 71. South Korea Bi-Specific MAbS Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 72. India Bi-Specific MAbS Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 73. Southeast Asia Bi-Specific MAbS Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 74. Australia Bi-Specific MAbS Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 75. South America Bi-Specific MAbS Sales Market Share by Type (2016-2026)

Figure 76. South America Bi-Specific MAbS Sales Market Share by Application (2016-2026)

Figure 77. South America Bi-Specific MAbS Revenue Market Share by Country (2016-2026)

Figure 78. Brazil Bi-Specific MAbS Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 79. Argentina Bi-Specific MAbS Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 80. Middle East and Africa Bi-Specific MAbS Sales Market Share by Type (2016-2026)

Figure 81. Middle East and Africa Bi-Specific MAbS Sales Market Share by Application (2016-2026)

Figure 82. Middle East and Africa Bi-Specific MAbS Revenue Market Share by Country (2016-2026)

Figure 83. Turkey Bi-Specific MAbS Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 84. Saudi Arabia Bi-Specific MAbS Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 85. UAE Bi-Specific MAbS Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 86. Methodology

Figure 87. Research Process and Data Source